These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1407 related articles for article (PubMed ID: 12549429)

  • 1. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
    Koprowski H
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
    Rupprecht CE; Hanlon CA; Slate D
    Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine requirements and priorities for developing countries.
    Thongcharoen P
    J Med Assoc Thai; 1986 Sep; 69(9):505-10. PubMed ID: 3794567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hunt for the AIDS vaccine.
    Essex M
    AIDS Asia; 1995; 2(3):10-3. PubMed ID: 12319586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
    Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
    Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant based HIV-1 vaccine candidate: Tat protein produced in spinach.
    Karasev AV; Foulke S; Wellens C; Rich A; Shon KJ; Zwierzynski I; Hone D; Koprowski H; Reitz M
    Vaccine; 2005 Mar; 23(15):1875-80. PubMed ID: 15734059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The present status of rabies vaccine development and clinical experience with rabies vaccine.
    Roumiantzeff M
    Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
    Seroka D
    Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of animal bites and rabies cases in India. A multicentric study.
    Ichhpujani RL; Mala C; Veena M; Singh J; Bhardwaj M; Bhattacharya D; Pattanaik SK; Balakrishnan N; Reddy AK; Samnpath G; Gandhi N; Nagar SS; Shiv L
    J Commun Dis; 2008 Mar; 40(1):27-36. PubMed ID: 19127666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technologies for vaccines.
    Dorner F; Eibl J; Barrett PN
    Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.